GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Uniphar PLC (FRA:0NR) » Definitions » EV-to-EBIT

Uniphar (FRA:0NR) EV-to-EBIT : 11.87 (As of May. 22, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Uniphar EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Uniphar's Enterprise Value is €1,200 Mil. Uniphar's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €101 Mil. Therefore, Uniphar's EV-to-EBIT for today is 11.87.

The historical rank and industry rank for Uniphar's EV-to-EBIT or its related term are showing as below:

FRA:0NR' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.86   Med: 16   Max: 36.12
Current: 11.87

During the past 9 years, the highest EV-to-EBIT of Uniphar was 36.12. The lowest was 7.86. And the median was 16.00.

FRA:0NR's EV-to-EBIT is ranked better than
50.53% of 95 companies
in the Medical Distribution industry
Industry Median: 12.15 vs FRA:0NR: 11.87

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Uniphar's Enterprise Value for the quarter that ended in Dec. 2024 was €853 Mil. Uniphar's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €101 Mil. Uniphar's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 11.84%.


Uniphar EV-to-EBIT Historical Data

The historical data trend for Uniphar's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uniphar EV-to-EBIT Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only 20.51 24.43 16.54 13.35 8.73

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.54 - 13.35 - 8.73

Competitive Comparison of Uniphar's EV-to-EBIT

For the Medical Distribution subindustry, Uniphar's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uniphar's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Uniphar's EV-to-EBIT falls into.


;
;

Uniphar EV-to-EBIT Calculation

Uniphar's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1200.121/101.08
=11.87

Uniphar's current Enterprise Value is €1,200 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uniphar's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €101 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Uniphar  (FRA:0NR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Uniphar's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=101.08/853.413225
=11.84 %

Uniphar's Enterprise Value for the quarter that ended in Dec. 2024 was €853 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Uniphar's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €101 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Uniphar EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Uniphar's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Uniphar Business Description

Traded in Other Exchanges
Address
4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain and Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland.

Uniphar Headlines

No Headlines